Company CVAbout Fermenta Biotech Ltd 
Fermenta Biotech Ltd
Micro Cap
Pharmaceuticals & Drugs
Fermenta Biotech Limited was formerly incorporated as 'Duphar-Interfran Limited' in May, 1951. The Company name was changed to 'DIL Limited' in September, 2003 and later on, the name was further changed to 'Fermenta Biotech Limited' on October 17, 2019. The Company is engaged in the business of manufacturing and marketing of chemicals, bulk drugs, enzymes, pharmaceutical formulations and environmental solution products and renting and selling of properties.
Company Coordinates
Company Details
A-1501 DIL Complex Majiwada, Ghodbunder Road Thane One Thane (West) Maharashtra : 400610
Registrar Details
Link Intime India Pvt Ltd, C-13 Pannalal Silk Compound, L B S Marg, Bhandup , Mumbai
Capital StructureCapital Structure
Present Equity Capital
INR 14.72 Cr
Number of Shares
2.94 Cr
Face Value
INR 5.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
13-Feb-2020
2.94
14.72
19620658
5
Bonus Issue
13-Feb-2020
2.94
14.72
19620658
5
Bonus Issue
10-Oct-2019
98.1
4.91
637537
5
Scheme of Amalgamation
10-Oct-2019
98.1
4.91
637537
5
Scheme of Amalgamation
08-Aug-2018
45.86
2.29
2293198
5
Stock Split
08-Aug-2018
91.73
4.59
4586396
5
Bonus
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 0 Schemes
FIIs
Held by 2 FIIs (0.02%)
Promoter with highest holding
Krishna Datla (34.01%)
Highest Public shareholder
Rakesh Kantilal Shah (2.04%)
Individual Investors Holdings
32.31%
Board of Directors
Management
Designation
Remuneration
Satish Varma
Executive Director
1.37 cr
Srikant N Sharma
Company Sec. & Compli. Officer
0
Krishna Datla
Executive Chairman & WTD
1.37 cr
Rajeshwari Datla
Director
11.5 lacs
Sanjay Buch
Chairman & Independent Directo
12.3 lacs
Vinayak Hajare
Independent Director
12.5 lacs
Gopakumar G Nair
Independent Director
12.0 lacs
ANUPAMA DATLA DESAI
Executive Director
1.22 cr
Rajashri Santosh Kumar Ojha
Independent Director
8.2 lacs
Prashant Nagre
Managing Director
1.49 cr
Pramod Kasat
Independent Director
0
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
No Data Available for Raw Material Segmentation
No Data Available
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Rent
15.66
80.93%
Service Income
2.99
15.43%
Security Deposits
0.70
3.63%
Rent
Rent
Service Income
Service Income
Security Deposits
Security Deposits
Stock DNARevenue and Profits:
Net Sales:
156 Cr
(Quarterly Results - Dec 2024)
Net Profit:
37 Cr
Pharmaceuticals & Drugs
INR 792 Cr (Micro Cap)
22.00
33
0.48%
0.30
2.92%
2.66
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
